MK-1775 is a potent inhibitor of the tyrosine kinase enzyme Wee1. The Wee enzymes are negative regulators of the cell cycle via phosphorylation of critical enzymes that activate mitosis. MK-1775 enhances the cytotoxic effects of various anti-cancer drugs, including 5-fluorouricil. The compound is currently in Phase 2 clinical trials. | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / Science Source / Greg Williams |
Bildgröße: | 6300 px × 3000 px |
Modell-Rechte: | nicht erforderlich |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: | - |